Award recordCONTRACT

RLS (USA) INC.

PIID 36C24721P1060· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· 6505 · DRUGS AND BIOLOGICALS· FY2021· $411,250 net obligations· UEI UA3GDUKRYSM5· FL

Description

SOMASTIN

First action · last action
2021-07-02 · 2024-10-08
Transactions
9
First transaction's obligation
$74,000
Base + all options value (sum of deltas)
$440,764
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 9 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$489,270$0Base award · 2021-07-02 · this action $74,000 · running total $74,000Modification P00001 · 2022-04-26 · this action $49,395 · running total $123,395Modification P00002 · 2022-05-25 · this action $48,100 · running total $171,495Modification P00003 · 2022-05-26 · this action $140,486 · running total $311,981Modification P00004 · 2023-04-11 · this action $136,789 · running total $448,770Modification P00005 · 2023-05-30 · this action $40,500 · running total $489,270Modification P00006 · 2024-10-08 · this action -$36,045 · running total $453,225Modification P00007 · 2024-10-08 · this action -$22,636 · running total $430,589Modification P00008 · 2024-10-08 · this action -$19,339 · running total $411,250
  • Base2021-07-02+$74,000= $74,000
  • Mod P000012022-04-26+$49,395= $123,395
  • Mod P000022022-05-25+$48,100= $171,495
  • Mod P000032022-05-26+$140,486= $311,981
  • Mod P000042023-04-11+$136,789= $448,770
  • Mod P000052023-05-30+$40,500= $489,270
  • Mod P000062024-10-08-$36,045= $453,225
  • Mod P000072024-10-08-$22,636= $430,589
  • Mod P000082024-10-08-$19,339= $411,250
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-07-02+$74,000$74,000SOMASTIN
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-04-26+$49,395$123,395SOMASTIN
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-05-25+$48,100$171,495SOMASTIN
Mod P00003· EXERCISE AN OPTION2022-05-26+$140,486$311,981SOMASTIN
Mod P00004· EXERCISE AN OPTION2023-04-11+$136,789$448,770SOMASTIN
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-05-30+$40,500$489,270SOMASTIN
Mod P00006· OTHER ADMINISTRATIVE ACTION2024-10-08−$36,045$453,225SOMASTIN
Mod P00007· OTHER ADMINISTRATIVE ACTION2024-10-08−$22,636$430,589SOMASTIN
Mod P00008· OTHER ADMINISTRATIVE ACTION2024-10-08−$19,339$411,250SOMASTIN

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI UA3GDUKRYSM5)

AwardOffice · PSC / listingNet obligationsFY
36C25626P0728256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$839,629FY2026
36C24526N0404245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$510,182FY2026
36C26126N0371261-NETWORK CONTRACT OFFICE 21 (36C261) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$250,075FY2026
36C26226N0409262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$1,561,204FY2026
36C26226N0410262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$752,000FY2026
36C25226P0239252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$303,486FY2026

Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0690SINA DRUG LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$188,463FY2026
36C24726N0211BOSTON SCIENTIFIC CORP247-NETWORK CONTRACT OFFICE 7 (36C247)$248,982FY2026
36C24726F0100AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$228,396FY2026
36C24726F0053EXELAN PHARMACEUTICALS INC247-NETWORK CONTRACT OFFICE 7 (36C247)$4,765,853FY2026
36C24726F0043AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$109,456FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24721P1060_3600_-NONE-_-NONE- · retrieved 2026-09-26.